Abstract
The TRPV1 receptor is known to play a role in nociceptive transmission in multiple organ systems, usually in response to the pain of inflammation. TRPV1 antagonism has so far shown limited benefit in antinociception. Capsaicin, a TRPV1 agonist, has been shown to induce a refractory period in the nerve terminal expressing TRPV1 and even, in sufficient dosing, to create long-term nerve terminal defunctionalization. This has led to research into topical capsaicin as a treatment for multiple painful conditions. The majority of work has focused on musculoskeletal pain and neuropathic pain and has revealed that although low-dose topical capsaicin has limited effectiveness as an analgesic, high-dose capsaicin, when tolerated, has the potential for long-term analgesia in certain types of neuropathic pain.
Howard Smith—deceased
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adcock JJ (2009) TRPV1 receptors in sensitisation of cough and pain reflexes. Pulm Pharmacol Ther 22:65–70. doi:10.1016/j.pupt.2008
Anand P, Bley K (2011) Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8 % patch. Br J Anaesth 107:490–502. doi:10.1093/bja/aer260
Argoff CE (2011) Review of current guidelines on the care of postherpetic neuralgia. Postgrad Med 123:134–142. doi:10.3810/pgm.2011.09.2469
Bevan S, Szolcsányi J (1990) Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol Sci 11:330–333
Brederson JD, Kym PR, Szallasi A (2013) Targeting TRP channels for pain relief. Eur J Pharmacol doi:pii: S0014-2999(13)00173-8. 10.1016/j.ejphar.2013.03.003
Cao E, Cordero-Morales JF, Liu B, Qin F, Julius D (2013) TRPV1 channels are intrinsically heat sensitiveand negatively regulated by phosphoinositide lipids. Neuron 77:667–679. doi:10.1016/j.neuron.2012.12.016
Casanueva B, Rodero B, Quintial C, Llorca J, González-Gay MA (2013) Short term efficacy of topical capsaicin therapy in severely affected fibromyalgia patients. Rheumatol Int 33(10):2665–2670
Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824
Chang HC, Chen ST, Chien SY, Kuo SJ, Tsai HT, Chen DR (2011) Capsaicin may induce breast cancer cell death through apoptosis-inducing factor involving mitochondrial dysfunction. Hum Exp Toxicol 30:1657–1665. doi:10.1177/0960327110396530
Chizh BA, O’Donnell MB, Napolitano A, Wang J, Brooke AC, Aylott MC, Bullman JN, Gray EJ, Lai RY, Williams PM, Appleby JM (2007) The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor mediated activity and inflammatory hyperalgesia in humans. Pain 132:132–141
Cianchetti C (2010) Capsaicin jelly against migraine pain. Int J Clin Pract 64:457–459. doi:10.1111/j.1742-1241.2009.02294.x
Clifford DB, Simpson DM, Brown S (2012) A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8 % Dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. J Acquir Immune Defic Syndr 59:126–133. doi:10.1097/QAI.0b013e31823e31f7
Cui M, Honore P, Zhong C, Gauvin D, Mikusa J, Hernandez G, Chandran P, Gomtsyan A, Brown B, Bayburt EK, Marsh K, Bianchi B, McDonald H, Niforatos W, Neelands TR, Moreland RB, Decker MW, Lee CH, Sullivan JP, Faltynek CR (2006) TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists. J Neurosci 26:9385–9393
Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, Hughes SA, Rance K, Grau E, Harper AJ, Pugh PL, Rogers DC, Bingham S, Randall A, Sheardown SA (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405:183–187
Derry S, Moore RA (2012) Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev 9:CD010111. doi:10.1002/14651858.CD010111
Derry S, Lloyd R, Moore RA, McQuay HJ (2009) Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database Syst Rev (4):CD007393. doi:10.1002/14651858.CD007393.pub2
Dworkin RH, O’Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, Kent JL, Krane EJ, LeBel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raja SN, Rice ASC, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco CA, Wells CD (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85:S3–S14. doi:10.4065/mcp.2009.0649
Engler A, Aeschlimann A, Simmen BR, Michel BA, Gay RE, Gay S, Sprott H (2007) Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritisand rheumatoid arthritis. Biochem Biophys Res Commun 359:884–888
Gavva NR, Treanor JJS, Garami A, Fang L, Surapaneni S, Akrami A, Alvarez F, Bak A, Darling M, Gore A, Jang GR, Kesslak JP, Ni L, Norman MH, Palluconi G, Rose MJ, Salfi M, Tan E, Romanovsky AA, Banfield C, Davar G (2008) Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 136:202–210. doi:10.1016/j.pain.2008.01.024
Haanpää M, Treede RD (2012) Capsaicin for neuropathic pain: linking traditional medicine and molecular biology. Eur Neurol 68:264–275. doi:10.1159/000339944
Huang D, Li S, Dhaka A, Story GM, Cao YQ (2012) Expression of the transient receptor potential channels TRPV1, TRPA1 and TRPM8 in mouse trigeminal primary afferent neurons innervating the dura. Mol Pain 8:66. doi:10.1186/1744-8069-8-66
Hutchinson MR, Buijs M, Tuke J, Kwok YH, Gentgall M, Williams D, Rolan P (2013) Low-dose endotoxin potentiates capsaicin-induced pain in man: Evidence for a pain neuroimmune connection. Brain Behav Immun pii:S0889–1591(13)00131-1. doi:10.1016/j.bbi.2013.03.002
Immke David C, Gavva Narender R (2006) The TRPV1 receptor and nociception. Semin Cell Dev Biol 17:582–591
Khairatkar-Joshi N, Szallasi A (2009) TRPV1 antagonists: the challenges for therapeutic targeting. Trends Mol Med 15:14–22. doi:10.1016/j.molmed.2008.11.004
Lambert GA, Davis JB, Appleby JM, Chizh BA, Hoskin KL, Zagami AS (2009) The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission. Naunyn Schmiedebergs Arch Pharmacol 380:311–325. doi:10.1007/s00210-009-0437-5
Li Q (2012) Antagonists of toll like receptor 4 maybe a new strategy to counteract opioid-induced hyperalgesia and opioid tolerance. Med Hypotheses 79:754–756. doi:10.1016/j.mehy.2012.08.021
Liddle RA (2007) The role of transient receptor potential vanilloid 1 (TRPV1) channels in pancreatitis. Biochim Biophys Acta 1772:869–878
Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ (2004) Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 328:991
McCleane G (2003) Pharmacological management of neuropathic pain. CNS Drugs 17:1031–1043
Nagy I, Sántha P, Jancsó G, Urbán L (2004) The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur J Pharmacol 500:351–369
Nilius B (2007) TRP channels in disease. Biochim Biophys Acta 1772:805–812
NICE Clinical Guideline 96 (2010) Neuropathic pain: The pharmacological management of neuropathic pain in adults in non-specialist settings. Issued: March 2010. National Institute for Health and Clinical Excellence. http://www.nice.org.uk/guidance/CG96. Accessed 24 April 2013
Premkumar LS, Abooj M (2013) TRP channels and analgesia. Life Sci 92:415–424. doi:10.1016/j.lfs.2012.08.010
Qutenza Prescribing Information (2009) Copyright 2009 NeurogesX
Richards BL, Whittle SL, Buchbinder R (2012) Neuromodulators for pain management in rheumatoid arthritis. Cochrane Database Syst Rev 1:CD008921. doi:10.1002/14651858.CD008921.pub2
Ro JY, Lee JS, Zhang Y (2009) Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia. Pain 144:270–277. doi:10.1016/j.pain.2009.04.021
Robbins WR, Staats PS, Levine J, Fields HL, Allen RW, Campbell JN, Pappagallo M (1998) Treatment of intractable pain with topical large-dose capsaicin: preliminary report. Anesth Analg 86(3):579–583
Rowbotham MC, Nothaft W, Duan WR, Wang Y, Faltynek C, McGaraughty S, Chu KL, Svensson P (2011) Oral and cutaneous thermosensory profile of selective TRPV1 inhibition by ABT-102 in a randomized healthy volunteer trial. Pain 152:1192–1200. doi:10.1016/j.pain.2011.01.051
Sayanlar J, Guleyupoglu N, Portenoy R, Ashina S (2012) Trigeminal postherpetic neuralgia responsive to treatment with capsaicin 8 % topical patch: a case report. J Headache Pain 13:587–589. doi:10.1007/s10194-012-0467-0
Schwartz ES, Christianson JA, LA Jun-Ho XC, Davis BM, Albers KM, Gebhart GF (2011) Synergistic role of TRPV1 and TRPA1 in pancreatic pain and inflammation. Gastroenterology 140:1283–1291. doi:10.1053/j.gastro.2010.12.033
Simpson DM, Estanislao L, Brown SJ, Sampson J (2008) An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy. J Pain Symptom Manage 35:299–306
Summ O, Holland PR, Akerman S, Goadsby PJ (2011) TRPV1 receptor blockade is ineffective in different in vivo models of migraine. Cephalalgia 31:172–180. doi:10.1177/0333102410375626
Takemura M, Quarcoo D, Niimi A, Dinh QT, Geppetti P, Fischer A, Chung KF, Groneberg DA (2008) Is TRPV1 a useful target in respiratory diseases? Pulm Pharmacol Ther 21:833–839. doi:10.1016/j.pupt.2008.09.005
Terenzi R, Romano E, Manetti M, Peruzzi F, Niacci F, Matucci-Cerinic M, Guiducci S (2013) Neuropeptides activate TRPV1 in rheumatoid arthritis fibroblast-like synoviocytes and foster IL-6 and IL-8 production. Ann Rheum Dis 72(6):1107–1109
Tominaga M, Tominaga T (2005) Structure and function of TRPV1. Pflugers Arch 451:143–150
Vardanyan A, Wang R, Vanderah TW, Ossipov MH, Lai J, Porreca F, King T (2009) TRPV1 receptor in expression of opioid-induced hyperalgesia. J Pain 10:243–252. doi:10.1016/j.jpain.2008.07.004
Webster LR, Nunez M, Tark MD, Dunteman ED, Lu B, Tobias JK, Vanhove GF (2011) Tolerability of NGX-4010, a capsaicin 8Â % dermal patch, following pretreatment with lidocaine 2.5Â %/prilocaine 2.5Â % cream in patients with postherpetic neuralgia. BMC Anesthesiol 11:25. doi:10.1186/1471-2253-11-25
Webster LR, Peppin JF, Murphy FT, Tobias JK, Vanhove GF (2012) Tolerability of NGX-4010, a capsaicin 8 % patch, in conjunction with three topical anesthetic formulations for the treatment of neuropathic pain. J Pain Res 5:7–13. doi:10.2147/JPR.S25272
Wong GY, Gavva NR (2009) Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks. Brain Res Rev 60:267–277. doi:10.1016/j.brainresrev.2008.12.006
Zhu Y, Colak T, Shenoy M, Liu L, Pai R, Li C, Mehta K, Pasricha PJ (2011) Nerve growth factor modulates TRPV1 expression and function and mediates pain in chronic pancreatitis. Gastroenterology 141:370–377. doi:10.1053/j.gastro.2011.03.046
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Basel
About this chapter
Cite this chapter
Smith, H., Brooks, J.R. (2014). Capsaicin-Based Therapies for Pain Control. In: Abdel-Salam, O. (eds) Capsaicin as a Therapeutic Molecule. Progress in Drug Research, vol 68. Springer, Basel. https://doi.org/10.1007/978-3-0348-0828-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0828-6_5
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0827-9
Online ISBN: 978-3-0348-0828-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)